Arkolith/Insider Trading/CADL/Form 4

Nichols William Garrett

Chief Medical OfficerCandel Therapeutics, Inc. (CADL) · full profile →Form 4 · filed Mar 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$397K
Net Open-Market Flow
-$397K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2025Option exercise(M)5K$3.75$17K84K
Mar 18, 2025Option exercise(M)14K$1.29$18K98K
Mar 18, 2025Sell(S)45K$8.76$397K52K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2025Option exercise(M)5K—$0195K
Mar 18, 2025Option exercise(M)14K—$031K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-042728) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML